ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

iPS-based medical research entering new stage, says scientist

Shinya Yamanaka

OSAKA -- Induced pluripotent stem cells will soon find their way out of laboratories and into hospital rooms for treatment of an array of ailments, said the scientist who discovered this potent tool in regenerative medicine.

     The cell research is "entering the second stage," said professor Shinya Yamanaka, the head of Kyoto University's Center for iPS Cell Research and Application, or CiRA. Speaking to The Nikkei Wednesday during a conference marking the 10-year anniversary of his groundbreaking discovery, the Nobel laureate said he expects iPS research to be used to treat Parkinson's disease, as well as ailments affecting blood and cartilage, in the near future.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more